OCS Oculis Holding AG

$12.94

Oculis Holding AG (OCS) is expected to report earnings on November 5, 2026, after the market close. The consensus earnings estimate is a loss of $0.49 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -0.1% since its last earnings release on August 6, 2026.

Oculis Holding AG Beat Consensus Estimates
Thursday, August 6, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 5
Thursday · 4:05 PM ET
Earnings Whisper
-
vs ($0.49)
Rev est $260K
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $12.79

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Oculis Holding AG

Oculis is a global biopharmaceutical company purposefully driven to save sight and improve eye care.

Sector

Healthcare

Industry

Biotechnology